Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{183636,
        author = {Neetu Devendra Singh and Spardha trehan},
        title = {A comparative study of DIPEPTIDYL PEPTIDASE – 4 INHIBITOR  WITH combination of  SULFONYLUREAS and metformin},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {3},
        pages = {2612-2619},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=183636},
        abstract = {Background: Insulin resistance is a hallmark of type 2 diabetes mellitus (T2DM), a chronic metabolic disease. progressive beta-cell dysfunction, necessitating combination pharmacotherapy for optimal glycemic control. Metformin remains the first-line agent; however, inadequate control often requires addition of either Dipeptidyl Peptidase-4 (DPP-4) inhibitors or sulfonylureas. This study aimed to compare The effectiveness, security, and acceptability of Metformin combined with DPP-4 inhibitors versus Metformin combined with sulfonylureas in those with T2DM who are not successfully managed with metformin alone},
        keywords = {},
        month = {August},
        }